中国
遗产管理(遗嘱认证法)
医学
家庭医学
业务
政治学
法学
作者
Houyu Zhao,Yiyuan Sun,Xi Yao,Peng Shen,Hongbo Lin,Siyan Zhan
标识
DOI:10.1080/14787210.2024.2368823
摘要
In 2017 and 2021, the National Medical Products Administration (NMPA) announced to revise the drug label of fluoroquinolones. We aimed to evaluate the association of fluoroquinolone prescribing with the NMPA announcements of label changes.
科研通智能强力驱动
Strongly Powered by AbleSci AI